How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Buy
56
CRVL Quote, Financials, Valuation and Earnings
Last price:
$112.15
Seasonality move
:
2.94%
Day range:
$109.55 - $111.71
52-week range:
$76.20 - $128.61
Dividend yield:
0%
P/E ratio:
65.51x
P/S ratio:
6.65x
P/B ratio:
19.01x
Volume:
81.4K
Avg. volume:
100.8K
1-year change:
27.05%
Market cap:
$5.7B
Revenue:
$795.3M
EPS (TTM):
$1.70
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, CorVel has -- downside to fair value with a price target of -- per share.
CRVL vs. S&P 500
-
Over the past 5 trading days, CorVel has overperformed the S&P 500 by 4.85% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
CorVel does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CorVel has grown year-over-year revenues for 15 quarters straight. In the most recent quarter CorVel reported revenues of $228M.
Earnings Growth
-
CorVel has grown year-over-year earnings for 7 quarters straight. In the most recent quarter CorVel reported earnings per share of $0.46.
Enterprise value:
5.6B
EV / Invested capital:
--
Price / LTM sales:
6.65x
EV / EBIT:
50.47x
EV / Revenue:
6.38x
PEG ratio (5yr expected):
3.63x
EV / Free cash flow:
67.35x
Price / Operating cash flow:
70.19x
Enterprise value / EBITDA:
40.05x
Gross Profit (TTM):
$195.2M
Return On Assets:
18.05%
Net Income Margin (TTM):
10.12%
Return On Equity:
33.19%
Return On Invested Capital:
33.19%
Operating Margin:
13.51%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $704.5M | $773.5M | $871.3M | $202.3M | $228M | |
| Gross Profit | $159.4M | $170.2M | $195.2M | $42.2M | $52.9M | |
| Operating Income | $88.2M | $95.1M | $110.1M | $22.4M | $30.8M | |
| EBITDA | $113.1M | $120.9M | $138.7M | $29.1M | $38.3M | |
| Diluted EPS | $1.27 | $1.44 | $1.70 | $0.33 | $0.46 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $259.2M | $268.7M | $256.7M | $294.4M | $383.2M | |
| Total Assets | $457.9M | $423.7M | $407.7M | $445M | $538.8M | |
| Current Liabilities | $158.8M | $170.5M | $186.4M | $188.4M | $216.7M | |
| Total Liabilities | $248M | $208.8M | $212.9M | $211.5M | $237.9M | |
| Total Equity | $209.9M | $214.9M | $194.8M | $233.5M | $300.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $86.3M | $96.8M | $119.6M | $29.4M | $41.6M | |
| Cash From Investing | -$30.5M | -$26.3M | -$37.1M | -$6.9M | -$9.5M | |
| Cash From Financing | -$93.3M | -$41.5M | -$26.5M | -$7.2M | -$7.5M | |
| Free Cash Flow | $55.8M | $70.4M | $82.5M | $22.5M | $32.1M | |
CRVL
Sector
Market Cap
$5.7B
$36.4M
Price % of 52-Week High
86.59%
44.07%
Dividend Yield
0%
0%
Shareholder Yield
0.66%
-1.03%
1-Year Price Total Return
27.05%
-41.85%
Beta (5-Year)
1.062
0.775
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$109.95
200-day SMA
Buy
Level
$105.96
Bollinger Bands (100)
Sell
Level
107.78 - 119.48
Chaikin Money Flow
Buy
Level
336.2K
20-day SMA
Buy
Level
$108.12
Relative Strength Index (RSI14)
Buy
Level
54.14
ADX Line
Buy
Level
21.23
Williams %R
Sell
Level
-15.0433
50-day SMA
Sell
Level
$112.20
MACD (12, 26)
Buy
Level
30.29
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Neutral
Level
293.7K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (18.2915)
Buy
CA Score
(Annual)
Level (1.4203)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.1687)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.
Stock Forecast FAQ
In the current month, CRVL has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CRVL average analyst price target in the past 3 months is --.
-
Where Will CorVel Stock Be In 1 Year?
According to analysts, the consensus estimate is that CorVel share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About CorVel?
Analysts are divided on their view about CorVel share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CorVel is a Sell and believe this share price will rise from its current level to --.
-
What Is CorVel's Price Target?
The price target for CorVel over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CRVL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CorVel is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CRVL?
You can purchase shares of CorVel via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CorVel shares.
-
What Is The CorVel Share Price Today?
CorVel was last trading at $112.15 per share. This represents the most recent stock quote for CorVel. Yesterday, CorVel closed at $111.36 per share.
-
How To Buy CorVel Stock Online?
In order to purchase CorVel stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 31
Ajinomoto [AJINY] is down 2.15% over the past day.
Sell
40
RGC alert for Mar 31
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
69
AGX alert for Mar 31
Argan [AGX] is down 4.98% over the past day.
